title: Effects of conjugated estrogen on the calcitriol response to parathyroid hormone in postmenopausal women.
abstract: We evaluated the effects of estrogen on the calcitriol response to the active peptide, human PTH(1-34), in postmenopausal women. Fifteen women were studied before and again after at least 1 month of treatment with conjugated equine estrogens, 1.25 mg/day. Six women received two series of four graded peptide infusions, each with the sequence 200, 400, 800, and 1600 USP U hPTH(1-34). Nine women received only one dose of peptide, either 200 or 800 U, before and while taking estrogen. Baseline values and the incremental and percent changes in circulating calcitriol 24 h after the 20-min infusions were evaluated. Estrogen treatment resulted in significant reductions in blood levels of calcium (2.26 +/- 0.03 mmol/L vs. 2.16 +/- 0.02, P less than 0.05) and phosphorus (1.23 +/- .05 mmol/L vs. 1.14 +/- 0.03, P less than 0.005), a rise in serum calcitriol concentrations (42.2 +/- 3.9 pg/mL vs. 28.6 +/- 3.1, P less than 0.005), and no change in circulating PTH. The rise in calcitriol after 200 U hPTH(1-34) was significantly greater on estrogen (17.6 +/- 2.0 pg/mL vs. 9.5 +/- 1.8, P less than 0.01), but estrogen did not alter incremental responses to larger doses. When results were normalized for differences in baseline values, the estrogen-related change in response to 200 U was no longer significant. hPTH(1-34) acutely increased urinary clearance of cAMP and phosphorus, but estrogen did not affect this response. We conclude that exogenous estrogen does not increase renal sensitivity to PTH in postmenopausal women.
authors.affiliation: Department of Medicine, Stanford University, California 94305.
authors.forename: R
authors.initials: R
authors.lastname: Marcus
authors.forename: M L
authors.initials: ML
authors.lastname: Villa
authors.forename: M
authors.initials: M
authors.lastname: Cheema
authors.forename: C
authors.initials: C
authors.lastname: Cheema
authors.forename: K
authors.initials: K
authors.lastname: Newhall
authors.forename: L
authors.initials: L
authors.lastname: Holloway
mesh_terms: D002117:Calcitriol / Q000097:blood*; D002118:Calcium / Q000097:blood; D000242:Cyclic AMP / Q000097:blood; D015914:Estrogen Replacement Therapy; D004966:Estrogens, Conjugated (USP) / Q000494:pharmacology*; D005215:Fasting; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood / Q000494:pharmacology*; D010446:Peptide Fragments / Q000494:pharmacology*; D010710:Phosphates / Q000097:blood / Q000652:urine; D019379:Teriparatide
chemical_list: D004966:Estrogens, Conjugated (USP); D010281:Parathyroid Hormone; D010446:Peptide Fragments; D010710:Phosphates; D019379:Teriparatide; D000242:Cyclic AMP; D002117:Calcitriol; D002118:Calcium